| Select | Gene | Cds | Cds_length | GC_content | Pep | Pep_length |
|---|---|---|---|---|---|---|
| Car05g02156 | ATGGACGTGAAAAACAGGGGAGTTTCATTGATAATATTATCGCTCTTTCTGTTACTTTCTTCTATTTTCTCTTCAGCCAATCGAATTATCCACAACAACAACCTAAAAAAAAATCCAATTTCTTTTCATTCCCTCGTTTCCTCTACCATTTACTCCATTCAAGGAAATGTATATCCACTTGGGTTTTACACAGTGACCTTGAACATTGGCAATCCACCAAAGCCTTACGACCTTGACATTGACACTGGGAGTGATATCACATGGATTCAGTGTGATGCACCATGTACAGGTTGCACCAAGCCTGTAGAACAACTTTATAAACCGCATAATAACATTGTGAAATGTACGGATCCCGTATGCGCTGCAATTCAAAATCATCACTGTGATGACCCGAATCATCAGTGTGATTACGAGGTTCTGTATGTAGATCATGGATCATCTCTTGGGGTATTAGTCCGAGACAATTTTCCTATTGGAACATCTAGCAGTGGATCTCTACTACAACCTTTGGTGGCATTTGGGTGTGGGTACGATCAAGAGTTTTCTGGTCCAAATCCGCCACCTGACACAATAGGGGTTCTTGGGCTTGGCAGTGGAAAAACAAGCATTTTATCACAGCTTAGCTCTCAAGGATATATTCGTAATGTGTTGGGTCACTGCTTAAGTTCCAAAGGAGGAGGGTATTTATTCTTTGGAGACCAATTTGTTCCATCATCTGGAATTAATTGGACACCTTTAATTCAGAATTCTCCAGAACAACACTATAACACGGGTCCAGCAGACATACTTTTTAATGGAATGCCAACTTCAGTCAAGAATATTCAACTTATTTTTGATAGTGGAAGCTCCTACACTTACTTCAATTCTGAAGCTTATAACGCTGTTGTTGCTCTGGTGAAAAATGATGTAAAAGGGAAGCTTAGTGATGCATCTGATGATCCATCATTGCCAATTTGTTGGAAGGGTGCGGAGCCTTTCAAATCTTTGAGTGATGTTGATACTTATTTTAAGCCCCTGGATCTAAGTTTCAGCAAATCAAATGATTTGTATTTTCATCTTCCACCTTCAGCTTATCTAATAATAACAGAACATGGTAACGTTTGCTTGGGGATTCTTGACGGCTCTCAAGTAGACCTAGGAGATCTTAACGTAATTGGAGATATCTTTTTGCAAGATAAGGTAGTGATTTATGACAACGAGAACAAACGAGTTGGATGGGCCTCTGCGGATTGTAATACACATCCACACCCATAA | 1254 | 0.3971 | MDVKNRGVSLIILSLFLLLSSIFSSANRIIHNNNLKKNPISFHSLVSSTIYSIQGNVYPLGFYTVTLNIGNPPKPYDLDIDTGSDITWIQCDAPCTGCTKPVEQLYKPHNNIVKCTDPVCAAIQNHHCDDPNHQCDYEVLYVDHGSSLGVLVRDNFPIGTSSSGSLLQPLVAFGCGYDQEFSGPNPPPDTIGVLGLGSGKTSILSQLSSQGYIRNVLGHCLSSKGGGYLFFGDQFVPSSGINWTPLIQNSPEQHYNTGPADILFNGMPTSVKNIQLIFDSGSSYTYFNSEAYNAVVALVKNDVKGKLSDASDDPSLPICWKGAEPFKSLSDVDTYFKPLDLSFSKSNDLYFHLPPSAYLIITEHGNVCLGILDGSQVDLGDLNVIGDIFLQDKVVIYDNENKRVGWASADCNTHPHP | 417 |
| Select | Seq ID | Length | Analysis | Description | Start | End | IPR | GO |
|---|---|---|---|---|---|---|---|---|
| Car05g02156 | 417 | Pfam | Xylanase inhibitor N-terminal | 63 | 233 | IPR032861 | - | |
| Car05g02156 | 417 | Gene3D | Acid Proteases | 38 | 233 | IPR021109 | - | |
| Car05g02156 | 417 | ProSitePatterns | Eukaryotic and viral aspartyl proteases active site. | 276 | 287 | IPR001969 | GO:0004190|GO:0006508 | |
| Car05g02156 | 417 | PANTHER | EUKARYOTIC ASPARTYL PROTEASE FAMILY PROTEIN | 2 | 414 | - | - | |
| Car05g02156 | 417 | SUPERFAMILY | Acid proteases | 56 | 413 | IPR021109 | - | |
| Car05g02156 | 417 | Gene3D | Acid Proteases | 234 | 414 | IPR021109 | - | |
| Car05g02156 | 417 | ProSitePatterns | Eukaryotic and viral aspartyl proteases active site. | 78 | 89 | IPR001969 | GO:0004190|GO:0006508 | |
| Car05g02156 | 417 | PANTHER | ASPARTYL PROTEASES | 2 | 414 | IPR001461 | GO:0004190|GO:0006508 | |
| Car05g02156 | 417 | PRINTS | Pepsin (A1) aspartic protease family signature | 69 | 89 | IPR001461 | GO:0004190|GO:0006508 | |
| Car05g02156 | 417 | PRINTS | Pepsin (A1) aspartic protease family signature | 276 | 287 | IPR001461 | GO:0004190|GO:0006508 | |
| Car05g02156 | 417 | PRINTS | Pepsin (A1) aspartic protease family signature | 383 | 398 | IPR001461 | GO:0004190|GO:0006508 | |
| Car05g02156 | 417 | ProSiteProfiles | Peptidase family A1 domain profile. | 63 | 407 | IPR033121 | - | |
| Car05g02156 | 417 | Pfam | Xylanase inhibitor C-terminal | 272 | 407 | IPR032799 | - |
| Select | Gene | Chromosome | Start | End | Duplicated_type |
|---|---|---|---|---|---|
| Car05g02156 | Car-Chr5 | 66789959 | 66792896 | Wgd |
| Select | Gene | Gene_start | Gene_end | Function | Ath_gene | Identity(%) | E-value | Score |
|---|---|---|---|---|---|---|---|---|
| Car05g02156 | 47 | 416 | Miscellaneous Gene Families | AT1G44130 | 55.200 | 1.74e-154 | 441 |
| Select | Query | KO | Definition | Second KO | KEGG Genes ID | GHOSTX Score |
|---|---|---|---|---|---|---|
| Car05g02156 | - | - | gmx:100803640 | 549.666 |
| Select | Gene_1 | Chr_1 | Start_1 | End_1 | Gene_2 | Chr_2 | Start_2 | End_2 | Event_name |
|---|---|---|---|---|---|---|---|---|---|
| Car04g02916 | 04 | 56270163 | 56274102 | Car05g02156 | 05 | 66789959 | 66792896 | PCT |